EUVIMEDEUVIMED entdecken
Beobachtungsstudie

NT-proBNP as a marker of coronary artery disease burden in chronic coronary syndromes

Mirko Schivalocchi, Riccardo Mazza, Carlo Gaspardone, Anna Rigatelli, Michele Morosato, Paolo Costa, Alessandro Gentile, Andrea Tripoli, Vincenzo Di Palma, Anna Salerno, Davide Maccagni, Matteo Montorfano und 3 weitere

International Journal of Cardiology · 2026

DOI: 10.1016/j.ijcard.2026.134752 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Cardiology, 2026. Verfasst von Mirko Schivalocchi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Natriuretic Peptide, Brain, Peptide Fragments, Coronary Artery Disease. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Evidence regarding the role of N-terminal pro-brain natriuretic peptide (NTproBNP) in chronic coronary syndrome (CCS) remains limited. We aimed to investigate the association between plasma NTproBNP levels and the presence and extent of coronary artery disease (CAD) in a prospective real-world cohort. METHODS: This prospective observational cross-sectional study included 676 consecutive patients (mean age 67 ± 7 years; 20% women) referred for elective coronary angiography for suspected CCS, as part of the BNP-CAD study (ClinicalTrials.govNCT07013344). Patients with conditions known to elevate NTproBNP were excluded. Obstructive CAD was defined as stenosis ≥70% (≥50% for the left main). Prognostically significant CAD was defined as involvement of the left main or proximal LAD artery. RESULTS: Obstructive CAD was identified in 432 patients (64%). NTproBNP levels were significantly higher in patients with obstructive CAD compared to those without (124 vs. 96 pg/mL, p < 0.001) and increased with the number of vessels involved and degree of stenosis. After adjustment for clinical confounders and high-sensitivity troponin T, NT-proBNP remained independently associated with obstructive CAD (OR per 100 pg/mL increase: 1.18; 95% CI: 1.03-1.36; p = 0.021). Prognostically significant CAD was present in 197 patients (46% of those with obstructive CAD) and was associated with higher NT-proBNP levels (133 vs. 107 pg/mL; p = 0.006), although discriminatory performance remained modest (AUC: 0.60; 95% CI: 0.55-0.64). CONCLUSION: NT-proBNP was independently associated with obstructive CAD and correlated with coronary disease burden. However, its modest discriminatory performance precludes its use as a stand-alone diagnostic test for high-risk coronary anatomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Natriuretic Peptide, BrainPeptide FragmentsCoronary Artery DiseaseHumansFemaleBiomarkersCross-Sectional StudiesProspective StudiesMaleAgedChronic DiseaseMiddle AgedCoronary AngiographyCohort Studies

Stichwörter der Autor:innen

Coronary angiographyMyocardial ischemiaN-terminal pro-brain natriuretic peptideNatriuretic peptidesStable angina

Substanzen

Natriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Biomarkers

Autor:innen und Institutionen

  • Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: gaspardone.carlo@hsr.it.
  • Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy; Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Clinical Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy; Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Clinical Cardiology Unit, IRCCS San Raff…

Zitieren

APA

Schivalocchi, M., Mazza, R., Gaspardone, C., Rigatelli, A., Morosato, M., Costa, P., Gentile, A., Tripoli, A., Di Palma, V., Salerno, A., Maccagni, D., Montorfano, M., Margonato, A., Metra, M., & Godino, C. (2026). NT-proBNP as a marker of coronary artery disease burden in chronic coronary syndromes. International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2026.134752

Vancouver

Schivalocchi M, Mazza R, Gaspardone C, Rigatelli A, Morosato M, Costa P, et al. NT-proBNP as a marker of coronary artery disease burden in chronic coronary syndromes. International Journal of Cardiology. 2026. doi:10.1016/j.ijcard.2026.134752

BibTeX
@article{Schivalocchi2026,
  author = {Schivalocchi, Mirko and Mazza, Riccardo and Gaspardone, Carlo and Rigatelli, Anna and Morosato, Michele and Costa, Paolo and Gentile, Alessandro and Tripoli, Andrea and Di Palma, Vincenzo and Salerno, Anna and Maccagni, Davide and Montorfano, Matteo and Margonato, Alberto and Metra, Marco and Godino, Cosmo},
  title = {NT-proBNP as a marker of coronary artery disease burden in chronic coronary syndromes},
  journal = {International Journal of Cardiology},
  year = {2026},
  doi = {10.1016/j.ijcard.2026.134752}
}
Kostenlos starten →